Status:
UNKNOWN
Dydrogesterone, Cetrorelix Acetate and Triptorelin in Intra Cytoplasmic Sperm Injection Outcomes
Lead Sponsor:
Beni-Suef University
Conditions:
IVF
Eligibility:
FEMALE
20-40 years
Phase:
PHASE3
Brief Summary
To compare the effects of Duphaston compared to GnRH agonist and antagonist on the prevention of premature LH surge and quality of retrieved oocytes and embryos in women undergoing intra-cytoplasmic s...
Detailed Description
Study Design: A randomized clinical trial (RCT). Study Site: The study will be conducted at Beni-Suef University Hospital Assisted Reproductive Techniques center. The study population includes all ...
Eligibility Criteria
Inclusion
- Having indications for ICSI.
Exclusion
- Any known contraindications to the approved fertility drugs.
- Severe endometriosis.
- Uterine malformations or abnormal uterine cavity.
- Uncontrolled endocrinopathies: DM, hyperthyroidism, hypothyroidism.
- Severe male factor for infertility.
Key Trial Info
Start Date :
July 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
387 Patients enrolled
Trial Details
Trial ID
NCT05972902
Start Date
July 15 2023
End Date
December 31 2023
Last Update
August 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beni-suef university Hospital
Banī Suwayf, Beni Suweif Governorate, Egypt, 62521